ACRIN 6690: A Prospective, Multicenter Comparison of Multiphase Contrast-Enhanced CT and Multiphase Contrast-Enhanced MRI for Diagnosis of Hepatocellular Carcinoma and Liver Transplant Allocation
Conditions
Liver Cancer
Trial Phase
Trial Purpose and Description
Trial Purpose
Participation Guidelines
- Age:
- 18 Years and older
- Gender:
- Both
Eligibility Criteria
- Sponsor:
- Yale
- Dates:
- December 2010
- Last Updated:
- Study HIC#:
- 1009007346
Clinicaltrials.gov ID: Yale0991741
For more information about this trial, contact:
Investigator
Jeffrey Weinreb, MD
Principal Investigator
